Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Banker

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Physical Review Letters|October 1, 2016
Direct Measurement of the Density Matrix of a Quantum SystemG S Thekkadath, L Giner, Y Chalich, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 15, 2014
Bis{(R)-N-[(R)-2-benz-yloxy-1-(4-tert-butyl-phen-yl)eth-yl]-2-methyl-propane-2-sulfinamide} monohydrateCharlotte L Humes, Tyler J Banker, Stephanie C M Dorn, et al.
Journal of Medicinal Chemistry|September 21, 2011
Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)Travis T Wager, Betty A Pettersen, Anne W Schmidt, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Physical Review Letters|October 1, 2016
Direct Measurement of the Density Matrix of a Quantum SystemG S Thekkadath, L Giner, Y Chalich, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 15, 2014
Bis{(R)-N-[(R)-2-benz-yloxy-1-(4-tert-butyl-phen-yl)eth-yl]-2-methyl-propane-2-sulfinamide} monohydrateCharlotte L Humes, Tyler J Banker, Stephanie C M Dorn, et al.
Journal of Medicinal Chemistry|September 21, 2011
Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)Travis T Wager, Betty A Pettersen, Anne W Schmidt, et al.
Pageof 2